Skip to main content
×
Home
    • Aa
    • Aa

The Alberta hip and knee replacement project: A model for health technology assessment based on comparative effectiveness of clinical pathways

Abstract

Background: The Alberta Hip and Knee Replacement Project developed a new evidence-based clinical pathway (NCP) for total hip (THR) and knee (TKR) replacement. The aim was to facilitate the delivery of services in a timely and cost-effective manner while achieving the highest quality of care for the patient across the full continuum of care from patient referral to an orthopedic surgeon through surgery, recovery, and rehabilitation. The purpose of this article is to provide an overview of the study design, rationale, and execution of this project as a model for health technology assessment based on comparative effectiveness of alternative clinical pathways.

Methods: A pragmatic randomized controlled trial study design was used to evaluate the NCP compared with the standard of care (SOC) for these procedures. The pragmatic study design was selected as a rigorous approach to produce high quality evidence suitable for informing decisions between relevant interventions in real clinical practice. The NCP was evaluated in three of the nine regional health authorities (RHAs) in Alberta with dedicated central intake clinics offering multidisciplinary care teams, constituting 80 percent of THR and TKR surgeries performed annually in Alberta. Patients were identified in the offices of twenty orthopedic surgeons who routinely performed THR or TKR surgeries. Evaluation outcome measures were based on the six dimensions of the Alberta Quality Matrix for Health (AQMH): acceptability, accessibility, appropriateness, effectiveness, efficiency and safety. Data were collected prospectively through patient self-completed questionnaires at baseline and 3 and 12 months after surgery, ambulatory and inpatient chart reviews, and electronic administrative data.

Results: The trial design was successful in establishing similar groups for rigorous evaluation. Of the 4,985 patients invited to participate, 69 percent of patients consented. A total of 3,434 patients were randomized: 1,712 to SOC and 1,722 to the NCP. The baseline characteristics of patients in the two study arms, including demographics, comorbidity as measured by CDS and exposure to pain medications, and health-related quality of life, as measured by Western Ontario and McMaster Universities Osteoarthritis Index and Short Form-36, were similar.

Conclusions: The Alberta Hip and Knee Replacement Project demonstrates the feasibility and advantages of applying a pragmatic randomized controlled trial to ascertain comparative effectiveness. This is a model for health technology assessment that incorporates how clinical pathways can be effectively evaluated.

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1.NK Aaronson , C Acquadro , J Alonso , International quality of life assessment (IQOLA) project. Qual Life Res. 1992;1:349351.

8.I Boutron , D Moher , DG Altman , KF Schulz , P Ravaud , CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med. 2008;148:295309.

9.DE Brunenberg MJ van Steyn , JC Sluimer , Joint recovery programme versus usual care: An economic evaluation of a clinical pathway for joint replacement surgery. Med Care. 2005;43:10181026.

11.DO Clark , M Von Korff , K Saunders , WM Baluch , GE Simon . A chronic disease score with empirically derived weights. Med Care. 1995;33:783795.

14.T Dixon , ME Shaw , PA Dieppe . Analysis of regional variation in hip and knee joint replacement rates in England using hospital episodes statistics. Public Health. 2006;120:8390.

16.SM Dy , P Garg , D Nyberg , Critical pathway effectiveness: Assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis. Health Serv Res. 2005;40:499516.

18.E Ernst , PH Canter . Limitations of “pragmatic” trials. Postgrad Med J. 2005;81:203.

19.N Freemantle , L Blonde , B Bolinder , Real-world trials to answer real-world questions. Pharmacoeconomics. 2005;23:747754.

20.LP Jr Garrison , PJ Neumann , P Erickson , D Marshall , CD Mullins . Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report. Value Health. 2007;10:326–35.

21.RE Glasgow , DJ Magid , A Beck , D Ritzwoller , PA Estabrooks . Practical clinical trials for translating research to practice: Design and measurement recommendations. Med Care. 2005;43:551557.

23.WL Healy , ME Ayers , R Iorio , Impact of a clinical pathway and implant standardization on total hip arthroplasty: A clinical and economic study of short-term patient outcome. J Arthroplasty. 1998;13:266276.

24.NB Jain , LD Higgins , D Ozumba , Trends in epidemiology of knee arthroplasty in the United States, 1990–2000. Arthritis Rheum. 2005;52:39283933.

27.EA Lingard , S Berven , JN Katz , Kinemax Outcomes Group. Management and care of patients undergoing total knee arthroplasty: Variations across different health care settings. Arthritis Care Res. 2000;13:129136.

28.A Macario , M Horne , S Goodman , The effect of a perioperative clinical pathway for knee replacement surgery on hospital costs. Anesth Analg. 1998;86:978984.

29.SJ Macdonald , KD Charron , RB Bourne , The John Insall Award: Gender-specific total knee replacement: Prospectively collected clinical outcomes. Clin Orthop Relat Res. 2008;466:26122616.

30.H Macpherson . Pragmatic clinical trials. Complement Ther Med. 2004;12:136140.

31.AD McMahon . Study control, violators, inclusion criteria and defining explanatory and pragmatic trials. Stat Med. 2002;21:13651376.

33.M Panella , S Marchisio , F Di Stanislao . Reducing clinical variations with clinical pathways: Do pathways work? Int J Qual Health Care. 2003;15:509521.

34.SD Pearson , SF Kleefield , JR Soukop , EF Cook , TH Lee . Critical pathways intervention to reduce length of hospital stay. Am J Med. 2001;110:175180.

36.M Renholm , H Leino-Kilpi , T Suominen . Critical pathways. A systematic review. J Nurs Adm. 2002;32:196202.

37.P Rissanen , S Aro , H Sintonen , P Slatis , P Paavolainen . Quality of life and functional ability in hip and knee replacements: A prospective study. Qual Life Res. 1996;5:5664.

38.M Roland , DJ Torgerson . What are pragmatic trials? BMJ. 1998;316:285.

39.Roos EM. Effectiveness and practice variation of rehabilitation after joint replacement. Curr Opin Rheumatol. 2003;15:160162.

40.D Schwartz , J Lellouch . Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637648.

41.SM Teutsch , ML Berger , MC Weinstein . Comparative effectiveness: Asking the right questions, choosing the right method. Health Aff (Millwood). 2005;24:128132.

42.SR Tunis , DB Stryer , CM Clancy . Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:16241632.

47.GR Wilensky . Developing a center for comparative effectiveness information. Health Aff (Millwood). 2006;25:w572w585.

48.M Zwarenstein , S Treweek , JJ Gagnier , Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ. 2008;337:a2390.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
WORD
Supplementary Materials

Gooch supplementary materials
Supplementary lists

 Word (56 KB)
56 KB

Metrics

Altmetric attention score